〝杏輝〞如視點眼液0.1％

国家: 台湾

语言: 中文

来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

有效成分:

FLUOROMETHOLONE

可用日期:

杏輝藥品工業股份有限公司 宜蘭縣冬山鄉中山村中山路84、84之4、84之6、84之7號、冬山鄉中山村新寮路95、95之1、100之7、100之13、100之15、100之16、103、136號 (42042734)

ATC代码:

S01BA07

药物剂型:

點眼液劑

组成:

FLUOROMETHOLONE (8406001200) 1MG

每包单位数:

塑膠瓶裝

类:

製　劑

处方类型:

須由醫師處方使用

厂商:

杏輝藥品工業股份有限公司 宜蘭縣冬山鄉中山村中山路８４號 TW

治疗领域:

fluorometholone

疗效迹象:

外眼部和前眼部之炎症性疾患。

產品總結:

有效日期: 2024/08/23; 英文品名: VISCONE EYE DROPS 0.1% "SINPHAR"

授权日期:

1999-08-23

资料单张

0.1%
Viscone
Eye Drops 0.1%
043184
G-6805
100
25
0.1% Fluorometholone
Dexa
methasone
Fluorometholone
Fluorometholone
Dexamethasone
mL
Fluorometholone...................................1.00mg
Partially hydrolyzed polyvinyl alcohol
Sodium phosphate
dibasic heptahydrate
Sodium phosphate monobasic
Sodium chloride
EDTA-2Na
Benzalkonium chloride
Polysorbate 80
Water for injection
1
2
2
4
24
48
4
1
2
PIC/S GMP
8 4
SINPHAR PHARMACEUTICAL CO., LTD.
84, CHUNG SHAN ROAD, CHUNG SHAN VILLAGE, TUNG - SHAN SHINE, I - LAN,
TAIWAN
[phone]
website
h t t p
//www.sinphar.com
R
PIC/S GMP
Viscone
Eye Drops 0.1%
Viscone eye drops is a topical cortisteroids anti-inflammatory product
for
ophthalmic use. Cortisteroids are capable of producing a rise in
intraocular
pressure. In clinical studies of doccumented steroid-responders,
flurometholone demonstrated a significantly longer average time to
produce
a rise in intraocular pressure than dexamethasone phosphate.
Composition: Each mL contains:
Fluorometholone..................................1.00mg
Other ingredients
Partially hydrolyzed polyvinyl alcohol,Sodium phosphate
dibasic heptahydrate,Sodium phosphate monobasic,
Sodium chloride,EDTA-2Na,Benzalkonium chloride,
Polysorbate 80,Water for injection
Indications:
Viscone eye drops is indicated for the treatment of corticoster oid-
responsive inflammation of the palpelbral and bulbar
conjunctiva, cornea and anterior segment of the globe.
Dosage and Administration:
Instill one or two drops of solution into the conjunctival sac two to
four times daily. During the initial 24 to 48 hours the dosage may be
increased to one application every four hours.
Care should be taken not to discontinue therapy prematurely.
Warnings:
- Use in the treatment of Herpes simplex requires great caution.
- This drug is not effective in the treatment of Sjogren's
keratoconjun-
ctivitis.
- Prolonged use may result in glaucoma, damage to the optic nerve,
defects in visual acuity and visual field, cataract formation.
- In acute purulent infection of the eye, infec